Bloomberg Law
Sept. 1, 2020, 9:10 PM

Contaminated Drugs Prompt FDA Request for Manufacturing Audits

Jacquie Lee
Jacquie Lee

Drug companies should audit their ingredient supply chains and manufacturing processes to protect consumers from potentially cancer-causing agents, the FDA said Tuesday after investigating several types of popular medicines that contained carcinogens.

The policy focuses on nitrosamine, which at high levels could can cause cancer in humans. A spate of high-profile drug recalls over the past couple of years spotlighted quality control issues in some types of drugs. The recalls included a popular heart-burn medicine commonly known as Zantac, which the FDA pulled from shelves permanently in April.

The contamination concern extends to some of the biggest names in the ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.